Type 2 Diabetes

New England CEPAC
November 14, 2019 10am-4pm ET

TBD
Providence, RI

The New England CEPAC will convene to deliberate on ICER's review of oral semaglutide for the treatment of type 2 diabetes.

Key Dates

Associated Materials

04/11/2019 – 04/29/2019
Open Input Period

05/02/2019
Draft Scoping Document

05/02/2019
Stakeholder List

05/02/2019 – 05/22/2019
Public Comment

05/31/2019
Revised Scoping Document

07/08/2019
Research Protocol

07/29/2019
Model Analysis Plan

09/11/2019
Draft Evidence Report

09/11/2019 – 10/08/2019
Public Comment

09/11/2019
Draft Voting Questions

10/31/2019
Revised Voting Questions

11/14/2019
Meeting Agenda

11/14/2019
Evidence Presentation

12/09/2019
Final Evidence Report and Meeting Summary

12/09/2019
Report-at-a-Glance